December 2016 Health Product InfoWatch is now available

The goal of the Health Product InfoWatch is to raise awareness and to provide clinically relevant information to healthcare professionals concerning marketed health products and their safety. In some cases, information is intended to stimulate reporting of similar adverse reactions. Each publication includes a monthly recap of health product advisories and summary safety reviews, as well as a growing selection of new health product safety information.

In this issue: 

• Monthly recap
• New information: 
  • Product monograph update: Erivedge (vismodegib)
  • Product monograph update: Invokana (canagliflozin) and Invokamet (canagliflozin and metformin hydrochloride)
  • Product monograph update: Rythmodan (disopyramide)